Online Program

Cuban Experience in Prevention, Care and Treatment of Diabetes and its Relevance for US Public Health

Wednesday, November 4, 2015 : 8:30 a.m. - 8:50 a.m.

Dabney Evans, PhD, MPH, Hubert Department of Global Health, Emory University, Atlanta, GA

In Cuba, an integrated, national strategy is one reason for low diabetes mortality—the lowest in the Americas—with decreases reported in 2011 and 2012. Another reason for this success is Cuba’s latest R&D breakthrough, a medication called Heberprot-P.

Learning Areas:

Chronic disease management and prevention
Planning of health education strategies, interventions, and programs
Public health or related public policy

Learning Objectives:
Compare diabetes management and care in the US and Cuba. Explain Cuba’s success in reducing mortality and improving quality of life compared to US experience.

Keyword(s): Diabetes, Chronic Disease Management and Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Assistant Professor of Global Health at the Hubert Department of Health in the Rollins School of Public Health at Emory University.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.